BioSymetrics
Pre-clinicalBioSymetrics is a phenomics-driven drug discovery company that integrates clinical and experimental data, using machine learning, to translate human disease biology and advance precision medicine. We are a remote-first company with offices in Boston and Toronto.
Founded
2016
Focus
AI / Machine Learning
About
BioSymetrics is a phenomics-driven drug discovery company that integrates clinical and experimental data, using machine learning, to translate human disease biology and advance precision medicine. We are a remote-first company with offices in Boston and Toronto.
Funding History
3Total raised: $37.5M
Series B$25MEight Roads VenturesMay 15, 2021
Series A$10MF-Prime CapitalOct 15, 2019
Seed$2.5MUndisclosedJun 15, 2017
Company Info
TypePrivate
Founded2016
LocationNew York, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile